• Shattuck Labs flagged two scientific posters for UEG Week 2026 in Barcelona, scheduled for Oct. 17-20.
• Data have not been presented yet; one poster is slated for a moderated session on Oct. 19.
• One presentation outlines preclinical work supporting SL-846, a bispecific antibody program aimed at inflammatory disease.
• A second poster evaluates immune-complex effects that could drive anti-drug antibodies, raising potential treatment-compatibility concerns in IBD.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shattuck Labs Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610130800PRIMZONEFULLFEED9844151) on October 13, 2026, and is solely responsible for the information contained therein.